内源性瘤性KRAS表达增加了接近二倍体的hTERT RPE-1细胞中的细胞增殖和运动性
相关实验视频
Updated: Jun 25, 2025

08:12
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
3.0K
Naushin L Hindul1, Lauren R Abbott1, Sumaya M D Adan1
1Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.
The Journal of biological chemistry
|May 25, 2024
概括
新的同源细胞系具有KRAS突变 (KRASG12V/+,KRASG12C/+,KRASG12D/+) 被创建以研究瘤性RAS信号. 这些模型揭示了不同的细胞行为和药物反应,有助于开发向癌症疗法.
科学领域:
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
- 药物发现 药物发现 药物发现
背景情况:
- 在人类癌症中,KRAS基因的突变很普遍,使其成为关键的治疗点.
- 尽管突变KRAS蛋白具有重要意义,但从历史上看,对药物进行有效向一直是具有挑战性的.
- 最近对RAS抑制剂的批准代表了进展,但有限的疗效和获得的耐药性等挑战仍然存在.
研究的目的:
- 在生理学上产生和表征具有特定瘤性KRAS突变 (G12V,G12C,G12D) 的同源细胞系.
- 研究这些KRAS突变对细胞增殖,运动和信号通路的影响.
- 评估这些突变细胞系对各种向抑制剂的差异反应.
主要方法:
- 产生接近二倍体的hTERT RPE-1同源细胞系,其内源KRAS基因基因突变为甘氨酸12 (G12V,G12C,G12D) 或野生型 (WT).
- 评估细胞增殖,移动性和焦点粘附动态.
- 对表皮生长因子 (EGF) 诱导的ERK和AKT信号通路的酸化的分析.
- 使用氧尿素,MEK抑制剂 (U0126,美替尼) 和PI3K抑制剂 (PIK-90) 的药物敏感性测定.
主要成果:
- 瘤性KRAS突变 (KRASG12X/+) 增加了细胞增殖和运动性,KRASG12V/+细胞显示焦点粘附减少.
- 在所有测试的KRAS基因型 (突变型和WT) 中,EGF诱导的ERK和AKT酸化是可比的.
- KRASG12X/+细胞表现出不同的药物敏感性:与WT细胞相比,KRASG12V/+和KRASG12D/+对氨酸urea和MEK抑制剂更敏感,但对PI3K抑制剂更耐药.
- 基尿素和U0126的组合表明了增增抑制,在KRASG12V/+细胞中更为明显.
结论:
- 生成的同源细胞系为研究在相关细胞环境中的瘤性RAS信号提供了宝贵的资源.
- 这些模型突出了与特定KRAS突变相关的差异性细胞表型和药物反应.
- 这些发现支持开发新型抗KRAS试剂和组合疗法,以提高疗效和减少对野生类型细胞的目标外影响.
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K

